Grant: REGENERX BIOPHARMACEUTICALS, INC.
REGENERX BIOPHARMACEUTICALS, INC.
CDFA Program Title
Trans-NIH Recovery Act Research Support
RegeneRx Biopharmaceuticals Inc. has the long-term goal of developing Thymosin Beta 4 (TB4), a naturally occurring peptide, for use in the treatment of ST-elevation myocardial infarction (STEMI). There are no pharmacological agents on the market to preven